SCHEMBL20007394

SCHEMBL20007394

COc1cc(C(=O)/C=C\Nc2cc(/C=C\c3cc(OC)c(OC)c(OC)c3)ccc2OC)ccc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ ABCG2 Q9UNQ0 4/20 0.53
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ TUBB1 Q9H4B7 6/20 0.50
▸ TUBB4A P04350 3/20 0.50
▸ TUBB P07437 3/20 0.50
▸ TUBA3C P0DPH7 3/20 0.50
▸ TUBA1B P68363 3/20 0.50
▸ TUBA4A P68366 3/20 0.50
▸ TUBB4B P68371 3/20 0.50
▸ TUBB3 Q13509 3/20 0.50
▸ TUBB2A Q13885 3/20 0.50
▸ TUBB8 Q3ZCM7 3/20 0.50
▸ TUBA3E Q6PEY2 3/20 0.50
▸ TUBA1A Q71U36 3/20 0.50
▸ TUBA1C Q9BQE3 3/20 0.50
▸ TUBB6 Q9BUF5 3/20 0.50
▸ TUBB2B Q9BVA1 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20007342 0.93 MEN1 (0.55) MEN1KMT2AABCG2CA1CA2
SCHEMBL17237310 0.93 MEN1 (0.66) MEN1KMT2AABCG2TUBB1TUBB4A
SCHEMBL17237306 0.93 MEN1 (0.66) MEN1KMT2AABCG2TUBB1TUBB4A
SCHEMBL17236833 0.91 ABCG2 (0.60) MEN1KMT2AABCG2TUBB1TUBB4A
SCHEMBL17236830 0.91 ABCG2 (0.60) MEN1KMT2AABCG2TUBB1TUBB4A
SCHEMBL17251595 0.89 CA1 (0.67) MEN1KMT2AABCG2CA1CA2
SCHEMBL17236858 0.88 TUBB1 (0.60) MEN1KMT2AABCG2CA1CA2
SCHEMBL17236855 0.88 TUBB1 (0.60) MEN1KMT2AABCG2CA1CA2
SCHEMBL20007437 0.88 ABCG2 (0.53) MEN1KMT2AABCG2CA1CA2
SCHEMBL17237231 0.88 TUBB1 (0.60) MEN1KMT2AABCG2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2942345-B1 3,4,5-TRIMETHOXYSTYRYLARYLAMINOPROPENONES FOR THE TREATMENT OF CANCER COUNCIL SCIENT IND RES (IN) 2018-03-28 — — EP disclosed
Send feedback